Two studies (#38 and #86) demonstrate that epigallocatechin-3-gallate can target cancer stem cells and enhance the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting the GRP78/NF-kappa B/miR-155-5p/MDR1 pathway. This evidence concerns the gene HSPA5 and colorectal cancer.